Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed
Read More Pharma Industry News Could THUNDERBOLT sharpen Penumbra’s stroke portfolio before the Boston Scientific deal closes? Find out how Penumbra’s THUNDERBOLT FDA clearance could reshape stroke thrombectomy and computer assisted clot removal. byPallavi MadhirajuJune 12, 2026